Net Medical Xpress Solutions, Inc. (NMXS) Comparison with companies in other sectors?

Net Medical Xpress Solutions, Inc. has a share price of 37.67M. You can analyze Net Medical Xpress Solutions, Inc. (NMXS) competitors across different market sectors through stock heatmaps.

What are NMXS's NET and operating margins?

Net Medical Xpress Solutions, Inc. (NMXS) operating margin is around -3.05, and net profit margin is approximately -3.11 as of the latest reports.

In what way does NMXS's earnings per share (EPS) trend reflect its financial momentum?

Net Medical Xpress Solutions, Inc. (NMXS) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Net Medical Xpress Solutions, Inc. is -0.01, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Net Medical Xpress Solutions, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Net Medical Xpress Solutions, Inc. like P/E which is -0.00, P/B which is -0.02, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Net Medical Xpress Solutions, Inc.

NMXS•PNK

Healthcare

Medical - Healthcare Information Services

$0.00

$0.00(0.00%)

Net Medical Xpress Solutions, Inc. (NMXS) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.01

P/E Ratio

-0.01

ROE

-2.50%

Net Margin

-3.11%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.77K

Shares OutstandingTotal number of shares issued

$37.67M

Book Value/ShareNet worth per share

$-0.00

Revenue/ShareAnnual revenue per share

$0.02

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

-311.06%

Operating MarginOperating income as percentage of revenue

-305.03%

ROEReturn on shareholders' equity

-249.76%

ROAReturn on total assets

-207.95%

ROCEReturn on capital employed

-376.24%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.02

Cash/ShareCash and equivalents per share

$0.008

FCF YieldFree cash flow as percentage of market cap

-18794.80%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NMXSFinancial Ratios Analysis details for NMXS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NMXSSector Benchmarking details for NMXS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Net Medical Xpress Solutions, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Net Medical Xpress Solutions, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Net Medical Xpress Solutions, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Net Medical Xpress Solutions, Inc.

For Net Medical Xpress Solutions, Inc., essential financial indicators include EPS -0.01, PE -0.01, and ROE -2.50. These key ratios reveal insights into Net Medical Xpress Solutions, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Net Medical Xpress Solutions, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Net Medical Xpress Solutions, Inc.

Metrics like Net Margin -311.06% and ROA -207.95% shed light on how well Net Medical Xpress Solutions, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Net Medical Xpress Solutions, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Net Medical Xpress Solutions, Inc.

Using ratios such as P/B Ratio -0.02 and PEG Ratio -0.00, investors can assess whether Net Medical Xpress Solutions, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Net Medical Xpress Solutions, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Net Medical Xpress Solutions, Inc.

Financial health indicators, such as Debt/Equity Ratio -5.13 and Cash Flow $-0.02, provide a snapshot of Net Medical Xpress Solutions, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Net Medical Xpress Solutions, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Net Medical Xpress Solutions, Inc.

Investing in Net Medical Xpress Solutions, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Net Medical Xpress Solutions, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;